Abstract:Introduction Deep vein thrombosis (DVT) poses a complex challenge and often leads to postthrombotic syndrome (PTS), a debilitating complication. The emergence of venous stents offers a potential preventive avenue against this complication. This study aimed to provide consensus recommendations on the use of venous stent for DVT. Materials and Methods From June to July 2023, 20 internal medicine, angiology and vascular surgery, and vascular and interventional radiology experts were involved in the Delphi process. Thirty-one recommendations, categorized into three thematic areas, were rigorously evaluated: indications for stent use, stent selection and placement, and monitoring and prevention of complications. Agreement was evaluated using a Likert scale, with consensus defined as agreement by two-thirds of the participants. Results Consensus was reached for 23 (74.2%) of 31 recommendations. The agreement was centered on considerations, such as stent placement in specific acute DVT scenarios, emphasizing pivotal stent characteristics. However, there were divergences in the recommended stent length to prevent migration and stent characteristics based on iliocaval bifurcation morphology. Notably, there was no consensus on whether patients with DVT caused by a major transient risk factor need more than 3 months of anticoagulation therapy or whether aspirin should be added to anticoagulant treatment after venous stenting. Conclusions These consensus recommendations offer practical insights into optimizing venous stent use to prevent PTS in DVT patients. Addressing the critical aspects of stent selection, placement, and postprocedural care, these recommendations contribute to clinical decision-making. The identified divergences underscore the importance of consensus and thus indicate the need for further investigation. Borja Castejón Navarro (Complejo hospitalario Ruber Juan Bravo, Madrid, Spain); Eduardo Crespo Vallejo (Fundación Jiménez Díaz, Madrid, Spain); Eva Criado Paredes (Corporació Sanitària Parc Taulí, Barcelona, Spain); Juan Fontcuberta García (Hospital de La Zarzuela, Hospital de la Moraleja, Madrid, Spain); Francisco Galeano Valle (Hospital Universitario Gregorio Marañón, Madrid, Spain); Íñigo Insausti Gorbea (Clínica Universitaria de Navarra, Pamplona, Spain); Luis Izquierdo Lamoca (Hospital Universitario HM Puerta del Sur, Madrid, Spain); Juan José López Núñez (Hospital Universitari Germans Trias i Pujol. Badalona, Barcelona, Spain); Alicia Lorenzo Hernández (Hospital Universitario La Paz, Madrid, Spain); Ana Maestre Peiró (Hospital Universitario de Vinalopó, Elche Alicante); Oscar Merino Mairal (Clínica Rotger Quironsalud, Palma, Spain); Manuel Jesús Núñez Fernández (Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain; Sonia del Pilar Otalora Valderrama (Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain); Maria Luisa Robles Martín (Hospital Quirónsalud, Málaga, Spain); Ruben Rodríguez Carvajal (Hospital Quirónsalud Campo de Gibraltar, Cádiz, Spain). Article published online: 11 May 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Anticoagulation in Patients with Isolated Distal Deep Vein Thrombosis: Bringing the Puzzle Together

Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study

Management of isolated distal deep vein thrombosis

Federal radiation initiatives wane in Reagan administration.

Therapeutic or Prophylactic Anticoagulation in Acute Isolated Distal Deep Vein Thrombosis: Protocol for a Prospective, Multicentre, Single-Blind, Randomised Controlled Trial (TOP-IDDVT)

Isolated Calf Muscle Venous Thrombosis: A Review of Anticoagulation Strategies

The clinical outcomes of different doses of rivaroxaban in patients with isolated distal deep vein thrombosis

Management of Deep Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline

[Dental care for patients, treated with an artificial kidney].

Anticoagulants for the treatment of isolated lower limb superficial vein thrombosis a Bayesian network meta-analysis of randomized controlled trials

Anticoagulation and compression therapy for proximal acute deep vein thrombosis

On the expression of nitric oxide synthase by human macrophages. Why no NO?

Three-Year Outcomes, Risk Factors for Restenosis After Stenting for DVT Combined with Iliac Vein Compression Syndrome

Observations on patients during the surgical treatment of acute massive hemorrhage from esophageal varices secondary to cirrhosis of the liver.

Randomized controlled trials of interventions for acute iliofemoral deep venous thrombosis

Risk factors and classification of reintervention following deep venous stenting for acute iliofemoral deep vein thrombosis

Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on the proliferation of herpes simplex virus type 1-transformed and thymidine kinase-deficient mouse cells.

Characteristics of Deep Venous Thrombosis in Isolated Lower Extremity Fractures and Unsolved Problems in Guidelines: A Review of Recent Literature

The short-term outcome of residual thrombus of the lower extremity after pharmacomechanical catheter-directed thrombolysis for deep vein thrombosis

Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis

Electrophysiology of Connection Current Spikes